Morning Brief — August 5, 2026

Market Overview

The S&P 500 and Dow are building on record highs as a powerful earnings season collides with easing geopolitical risk — hopes for a Strait of Hormuz reopening are pulling oil lower and lifting sentiment broadly. Palantir’s 30% post-earnings surge wiped out roughly $3B in short-seller gains and is dragging the AI trade higher, while Shopify’s “monster quarter” is lifting the e-commerce cohort. The macro backdrop — falling oil, rising equities, flat dollar — is textbook risk-on rotation away from defensives and into growth.

Claude’s Call

UP — The combination of a strong earnings tape (PLTR, SHOP, ZBRA, UFPT all crushing numbers), Hormuz de-escalation reducing the oil risk premium, and short-squeeze momentum in high-beta AI names creates a strong bull case for the session; expect the S&P 500 to press further into record territory with tech and industrials leading.

Top Movers

TSAT (+36.3%) — $54.75 → $67.80 (+23.9% upside) Thesis: This is the real deal — Telesat just signed a $1.9B, 15-year contract with the Canadian government for Arctic military Ka-band connectivity, the largest revenue contract in company history. This transforms the balance sheet narrative overnight and de-risks the Lightspeed constellation financing story that has plagued the stock. Technically, TSAT broke well above its 20-day high of $54.75 and is now running toward the fib 1.272 extension at $67.80 — this move has genuine fundamental legs, not just short-covering. Levels: Exit at Fib 1.272 extension $67.80. Support at Fib 23.6% retracement $50.45; SMA-50 at $44.53 is your hard stop.

APPS (+33.2%) — $12.67 → $16.50 (+30.2% upside) Thesis: Digital Turbine reported a clean 27% revenue beat for Q1 FY2027 at $166M and raised full-year guidance, powered by international OEM device business acceleration and AI-driven advertising demand. This is a genuine earnings-driven re-rating, not a sympathy bounce — the company’s AGP segment was already flagged growing 57% last quarter. At 6-month highs with volume confirmation (vol ratio 1.27, the only mover today with above-average volume), the stock is technically clean with the fib 1.272 extension at $16.50 as the next logical target. Levels: Exit at Fib 1.272 extension $16.50. Support at Fib 23.6% $11.04; SMA-50 $9.55 is your catastrophic stop.

W (+30.0%) — $116.08 → $132.04 (+13.7% upside) Thesis: Wayfair delivered its strongest post-pandemic U.S. revenue growth — US net revenue up 8.7% YoY to $3.12B — and management highlighted rapid Perigold premium brand expansion and new physical store openings. The housing/furniture recovery narrative is finally showing up in the numbers, not just management talk. However, be aware: W swung back to a net loss this quarter ($1M vs. $15M income last year), and the stock is now at its 6-month high with RSI neutral at 50. The move is justified but much of the good news is priced in at the $116 6-month ceiling. Levels: Exit at Fib 1.272 extension $132.04. Support at Fib 23.6% $102.23; SMA-50 $85.32.

PLTR (+29.5%) — $162.66 → $179.31 (+10.2% upside) Thesis: Palantir delivered EPS of $1.15 and is being described as “several steps ahead” in enterprise AI deployment, with $3B in short-seller pain adding fuel to the squeeze. The AI platform narrative is resonating — government and commercial AIP adoption is accelerating, and management tone is reportedly highly confident. But here’s the honest take: at 78x forward P/E vs. a peer median of 38x and EV/EBITDA of 143x vs. peers at 18.75x, you are paying a historically extreme premium. RSI is only 24 despite the surge — which is unusual and may reflect technical calculation anomalies with the new highs. Near-term fib 1.272 target is $179.31 but this is a name where the risk of a violent reversal is real. Levels: Exit at Fib 1.272 extension $179.31. Support at Fib 23.6% $150.54; SMA-50 $131.53.

BLZE (+26.9%) — $19.79 → $24.27 (+22.7% upside) Thesis: Backblaze signed the largest contract in company history — a $335M CoreWeave (CRWV) deal — while beating Q2 revenue guidance by $2.5M and raising full-year 2026 outlook. B2 cloud storage revenue grew 34% and Oppenheimer raised their target to $25. The CRWV partnership is a genuine structural catalyst tying Backblaze to the AI infrastructure buildout. The stock hit a 55-month high and RSI at 63.64 suggests it’s not yet overbought. The $335M deal is transformative for a company this size — this move has legs. Levels: Exit at Fib 1.272 extension $24.27. Support at Fib 23.6% $15.90; SMA-50 $12.09.

ZBRA (+26.5%) — $368.83 → $414.94 (+12.5% upside) Thesis: Zebra Technologies just reported record Q2 results — 20% sales growth, record EPS, and raised full-year guidance to $13.00-$13.30 (from $12.50-$13.10). Demand is strong across Connected Frontline and Asset Visibility/Automation segments. This is a clean earnings beat with guidance raise, not a sympathy trade. The stock is at 6-month highs and technically sitting just above the fib 1.272 target zone of $414.94. The only flag is memory supply constraints management mentioned — watch for that as a potential ceiling on upside. Levels: Exit at Fib 1.272 extension $414.94. Support at Fib 23.6% $328.82; SMA-50 $259.93.

SHOP (+21.8%) — $150.19 → $160.24 (+6.7% upside) Thesis: Shopify delivered $3.58B in Q2 revenue vs. $3.44B expected — a clean $140M / ~4% beat — on the back of GMV acceleration and international expansion. The headline “best single-day gain since 2015” is noteworthy but the honest read is that much of the upside has already been captured. At 62.6x forward P/E vs. peer median of 13x, this is an expensive name even for its ~34% growth rate (PEG of ~1.8 — fair but not cheap). RSI is 25.49, which is deep oversold territory and confirms this is a violent snap-back from a beaten-down base. Volume is running at 0.82x average — decent but not explosive. At current price, you’re already approaching analyst target of $148. Levels: Exit at Fib 1.272 extension $160.24. Support at Fib 23.6% $134.34; SMA-50 $117.54.

QLYS (+21.5%) — $195.75 → $224.95 (+14.9% upside) Thesis: Qualys reported 11% revenue growth, +11.24% EPS beat, and raised full-year guidance to $732M-$738M, driven by AI-native security solutions and improved upsell execution. The cybersecurity sector is benefiting from structural tailwinds and Qualys is executing cleanly. However, one analyst flags 41% overvaluation even after the guidance raise — this deserves respect. The stock has run 70% in 90 days, and while the fib 1.272 extension at $224.95 is reachable, risk/reward is less favorable after this surge. Genuine fundamental beat but chasing here requires conviction in the multiple expansion story. Levels: Exit at Fib 1.272 extension $224.95. Support at Fib 23.6% $165.55; SMA-50 $131.88.

AAOI (+19.4%) — $131.63 → $152.44 (+15.8% upside) Thesis: Applied Optoelectronics is riding a policy-driven catalyst — a reported (not yet final) U.S. ban on Chinese optical transceivers for data centers would be massive for domestic suppliers. AAOI jumped 17-19% on this news alongside Coherent (+11-13%) and Lumentum (+6-11%). The honest caveat: this is still a draft proposal, and Counterpoint Research warns no Western alternative can absorb China’s 2/3 global supply share in 1-2 years. This is real news but carry significant policy-reversal risk. Technically, AAOI is right at the fib 50% retracement support of $130.62 from the 6-month range — it’s recovering from a deep correction off the $223 high. Levels: Exit at Fib 38.2% resistance $152.44. Support at Fib 50% $130.62; below that $108.79.

YOU (+17.3%) — $65.36 → $77.56 (+18.7% upside) Thesis: CLEAR Secure delivered a genuine triple-beat: revenue up 26.6% YoY to $277.8M (+2.91% beat), EPS of $0.49 (+27.3% beat), and Q3 guidance of $285.5M (3.9% above consensus). This is clean fundamental execution with no asterisks. RSI of 19.15 is extraordinarily oversold, suggesting the stock was in a heavily beaten-down technical position before this catalyst — the re-rating has more room. The stock is at 6-month highs and the fib 1.272 extension at $77.56 is a reasonable near-term target. Levels: Exit at Fib 1.272 extension $77.56. Support at Fib 23.6% $59.43; SMA-50 $54.82.

WIX (+17.5%) — $66.78 → $67.16 (near-term resistance, then $108.43 longer) Thesis: Wix reported 15% revenue growth and 12% bookings growth in Q2, with the Base44 AI coding platform showing dramatically improved gross margins thanks to its proprietary Base 1 model. This is a real AI productivity story — not just hype — but the stock is down 34% YTD and 48% over the past year, meaning today’s move is a dead-cat bounce candidate as much as a recovery. Jefferies described results as “largely in line” — not a blowout. Technically, WIX is right at its 6-month high ($66.78) but remains well below the $93.89 six-month ceiling. Fib resistance immediately overhead at $67.16 (the fib 50% level from the 6-month range). Levels: Exit target $73.47 (fib 38.2%). Support at $60.85 (fib 61.8%); SMA-50 $50.95.

Headlines to Watch

“Telesat Lands Record $1.9B Canada Deal, Expands Lightspeed Constellation” — This is the most transformative single-company news of the day; TSAT’s 15-year government contract fundamentally changes its credit profile and makes the Lightspeed buildout viable — watch for analyst upgrades and target raises over the next 48 hours.
“Palantir’s 30% Surge Just Crushed the Short Trade — $3B in Paper Losses” — Short squeezes of this magnitude in mega-cap names ripple across the AI sector; expect continued pressure on PLTR shorts and sympathy buying in AI-adjacent names like BBAI, C3.ai, and SOUN.
“New Report Warns China Transceiver Ban Would Hurt U.S. AI Giants” — The Counterpoint Research report is a double-edged sword: it validates the supply-chain shift thesis for AAOI/Coherent/Lumentum but introduces execution risk on the timeline; the draft ban is not finalized and could be softened significantly.
“Wayfair Sees Recovery in U.S. Furniture Demand” — Wayfair’s CFO commentary on U.S. consumer recovery in discretionary categories is a read-through for the broader housing ecosystem; watch HD, LOW, and RH for sympathy reactions.
“Shopify Surges — AMD Slides Premarket as Earnings Disappoint” — AMD’s underwhelming AI revenue guidance continues to raise questions about whether the GPU/CPU spend is concentrating at NVDA at AMD’s expense; this is a meaningful divergence in the AI semiconductor narrative worth monitoring.
“S&P 500, Dow Build on Record Highs Amid AI and Iran Hope” — The Hormuz de-escalation story combined with AI earnings beats is the perfect bull setup, but this is the second consecutive day of record highs on geopolitical optimism — if the Hormuz deal stalls, the air can come out quickly.
“Backblaze BLZE Stock Hits 55-Month High — $335M CoreWeave Deal Impresses” — The BLZE/CRWV partnership signals that AI cloud infrastructure is creating a long tail of beneficiaries beyond the hyperscalers; this is a legitimate “picks and shovels” AI play at a fraction of the valuation of the Mag-7.

Claude’s Top Picks

TSAT (+36.3% today, +48.0% week) — $54.75 → $67.80 (+23.9% upside) Valuation: No forward P/E comp available, but a $1.9B 15-year government contract at a $600M market cap is transformative — this is a re-rating event, not a multiple expansion story. Upside: The Arctic military connectivity contract is the first de-risking of the Lightspeed financing story; analyst upgrades and institutional accumulation are likely over the next 1-2 weeks. Risk: The stock has already run 48% this week and sits at its 20-day high — any news that complicates the MDA satellite manufacturing relationship or Canadian government budget concerns could trigger a sharp reversal back to $50.45 support. Stop reference: Fib 23.6% support at $50.45

APPS (+33.2% today, +56.0% week) — $12.67 → $16.50 (+30.2% upside) Valuation: Forward P/E of 14.1x vs. peer median of 13.1x — essentially at fair value for a 27% revenue grower, which is a genuine bargain relative to the growth rate (PEG well below 1). Upside: Raised full-year guidance on AI-driven ad monetization and international OEM acceleration; at fair value with a real catalyst, there’s room to re-rate toward the fib 1.272 extension at $16.50. Risk: Volume ratio of 1.27x is confirmed but APPS has a history of fading hard after earnings pops — the stock was at $2.82 six months ago, suggesting the business has been restructuring; any guidance miss next quarter would be severely punished. Stop reference: Fib 23.6% support at $11.04

BLZE (+26.9% today, +64.0% week) — $19.79 → $24.27 (+22.7% upside) Valuation: EV/EBITDA of 1,189x vs. peer median of 18.75x is alarming on paper, but this is a pre-profit cloud storage name — EV/Revenue is the right lens, and the $335M CoreWeave contract alone is nearly equal to the current market cap, making traditional valuation metrics temporarily irrelevant. Upside: The CRWV deal is genuinely transformative — it provides multi-year revenue visibility and validates B2 Cloud as a credible AWS/Azure alternative for AI workloads; the Oppenheimer $25 price target implies another 26% from current levels. Risk: The shelf registration for $65.4M in new shares is a dilution overhang — management clearly intends to raise equity capital while the stock is elevated, and the RSI at 63.64 with the stock up 64% this week leaves limited margin for error. Stop reference: Fib 23.6% support at $15.90

YOU (+17.3% today, +11.9% week) — $65.36 → $77.56 (+18.7% upside) Valuation: No comps provided, but a 26.6% revenue grower with GAAP profitability (EPS $0.49, +27% beat) in identity verification deserves a premium multiple — the setup here is oversold recovery, not multiple expansion. Upside: RSI of 19.15 before the catalyst is the most technically oversold reading in today’s top-20 list — violent snap-backs from those levels often have 2-3 weeks of continuation; Q3 guidance of $285.5M (3.9% above consensus) means the next quarter is also de-risked. Risk: CEO sold $6.4M in shares recently as the stock was surging — insider distribution into strength is a yellow flag, and travel/airport volumes are a macro sensitivity not fully priced in if economic data softens. Stop reference: Fib 23.6% support at $59.43

ZBRA (+26.5% today, +29.7% week) — $368.83 → $414.94 (+12.5% upside) Valuation: No forward P/E comps provided, but 20% revenue growth with record EPS and raised guidance in an industrial automation name typically commands 25-35x forward earnings — the stock has run 61% in 90 days but the fundamental upgrade cycle is intact. Upside: Record Q2 results + guidance raise ($13.00-$13.30 full-year EPS) in warehouse automation and connected frontline is a durable secular theme; AI-driven logistics demand is not slowing, and Zebra is the dominant picks-and-shovels play. Risk: Management flagged memory supply constraints as an ongoing headwind — if chip supply tightens further, ZBRA’s ability to fulfill demand could cap revenue upside in H2; the stock is up 30% in one week which compresses near-term risk/reward. Stop reference: Fib 23.6% support at $328.82

Avoid

QLYS — Up 70% in 90 days on an 11% revenue grower; even with the guidance raise, one analyst flags 41% overvaluation, and the risk/reward after a 21% single-day move is deeply unfavorable — wait for a pullback to the $165 fib 23.6% level before considering entry.

PLTR — The earnings are real but 78x forward P/E and 143x EV/EBITDA vs. peer medians of 38x and 18.75x respectively means you are paying an extreme premium even for its 92.8% revenue growth — at $162.66 and already past the day’s open surge, you’re buying into a short-squeeze aftermath, not a fresh opportunity; the fib 1.272 extension at $179.31 is only 10% away while the fib 23.6% support is 7.4% below at $150.54 — the setup is not asymmetric.

GENVR — Up 75% this week at $2.68 with no company-specific news visible in the headlines (news flow is about GE Vernova/GEN Digital, not GENVR), near-zero volume relative to average (0.03x), and a micro-cap price; this has all the hallmarks of a thin-float momentum squeeze with no fundamental anchor — avoid entirely.

WSB Sentiment Check

AMD — WSB says: BULLISH (80% bullish, 1,255 mentions, 6,943 upvotes) Claude says: DISAGREE — AMD reported $3.22 EPS but the AI GPU revenue guidance disappointed Wall Street enough to send the stock down ~5% post-earnings; at $494 with the stock below its SMA-50 of $514.86 and well off the $580.91 six-month high, the chart is in a downtrend and WSB’s 80% bullish read looks like bag-holding rationalization — the fib 23.6% support at $488.88 is right at current price, but if that breaks, the next stop is $431.95 (fib 38.2%); the AI GPU share story remains intact long-term but short-term the setup is weak.

SPCX — WSB says: BULLISH (80% bullish, 700 mentions, 4,486 upvotes) Claude says: DISAGREE — SPCX (a SpaceX-linked ETF/vehicle) is trading at $110.10, which is essentially the 6-month low of $108.37 and down massively from the $211.39 six-month high; SpaceX’s first earnings report is noted as disappointing in today’s news flow, and the technical structure is a waterfall decline with no visible support; WSB’s SpaceX IPO enthusiasm is understandable but this vehicle is in freefall — buying into a fundamentally disappointing first earnings print at 6-month lows with no technical floor is pure speculation.

MU — WSB says: BEARISH (30% bullish, 329 mentions, 1,384 upvotes) Claude says: AGREE — Micron at $899.94 is sitting just below the fib 38.2% support at $872.77, down sharply from the $1,213.37 six-month high; the SMA-50 at $972.30 is overhead resistance now, not support; WSB’s bearish lean is technically correct — the memory cycle is at risk of rolling over and SNDK (SanDisk) data showing similar weakness confirms sector pressure; if $872.77 breaks, the fib 50% at $767.56 is the next target and that’s another 15% down.

NVDA — WSB says: BULLISH (80% bullish, 272 mentions, 1,068 upvotes) Claude says: AGREE — NVDA at $219.12 is at its 20-day high and sitting right at the fib 23.6% support of $218.83, having bounced cleanly off that level; SMA-50 at $205.73 is rising and the stock is above it; with Palantir’s AI results validating enterprise AI spend and the China optical ban potentially accelerating domestic AI capex, NVDA is the highest-quality way to play the AI infrastructure theme; the fib 1.272 extension at $254.64 is the near-term target and the setup is genuinely constructive.

SNDK — WSB says: MIXED (55% bullish, 264 mentions, 807 upvotes) Claude says: DISAGREE (lean bearish) — SanDisk at $1,400 is in a steep downtrend from $2,335 six months ago and sits well below the SMA-50 of $1,703.26; the fib 50% support level at $1,431.17 is just above current price — the stock is barely hanging above a critical support zone; the mixed WSB sentiment reflects genuine uncertainty, but the combination of memory sector headwinds (aligned with MU weakness), a broken chart structure, and proximity to fib 50% support without a clear catalyst makes the risk/reward unfavorable — this is a falling knife, not a value opportunity.

Earnings Scorecard

PLTR (Palantir Technologies) — EPS: $1.15 | Stock: +29.5% | Reported: Aug 4 After Close The reaction was justified and possibly still insufficient — at 92.8% revenue growth with AI platform adoption inflecting across both government and commercial segments, the fundamental story matches the price action; the $3B short squeeze is gasoline on the fire but the earnings quality appears genuine; this is a hold for longs / do not chase for new buyers at current extended levels.

SHOP (Shopify) — EPS: $1.02 | Stock: +21.8% | Reported: Aug 5 Before Open The reaction is justified — a $140M revenue beat (4%) with GMV acceleration is a genuine upside surprise from a deeply oversold RSI-25 base; however, at 62.6x forward P/E and already approaching the analyst target of $148, this is more sell-the-rip than buy-the-dip from current levels — the easy money was made at the open.

ANET (Arista Networks) — EPS: $2.99 | Stock: +12.2% | Reported: Aug 4 After Close The reaction was justified and measured — Arista’s first $3B quarter validates AI networking demand and is a clean beat; the +12% move is proportionate; the analyst target of $192.31 suggests limited near-term upside from here — hold existing positions, no fresh entry.

CVS (CVS Health) — EPS: $2.28 | Stock: -7.6% | Reported: Recent The negative reaction is overdone — CVS raised 2026 guidance and beat on both lines, yet the stock fell 7.6%, likely due to managed care margin pressures and pharmacy benefit headwinds; this looks like a buy-the-dip for value-oriented investors, though the structural PBM headwinds are a legitimate overhang.

AMD (Advanced Micro Devices) — EPS: $3.22 | Stock: -4.7% | Reported: Aug 4 After Close The reaction was justified — analysts described it as “not an exceptional result” and the AI GPU outlook “wasn’t enough”; AMD is losing mindshare to NVDA in data center AI and the -5% move reflects that; with the stock below its SMA-50 and in a technical downtrend, this is not a buy-the-dip situation — wait for $431.95 (fib 38.2%) before reassessing.

SPOT (Spotify) — EPS: $14.63 | Stock: +4.2% | Reported: Recent The reaction was insufficient on the upside — the stock barely rose despite an earnings beat, dragged down by a monthly active user forecast miss; this creates a potential buy-the-dip once the MAU guidance concern is digested, as Spotify’s monetization trajectory (EPS $14.63 is exceptional) is the more important long-term driver.

AMGN (Amgen) — EPS: $16.11 | Stock: +3.3% | Reported: Recent The reaction was fair — revenue surpassing $10B and raised guidance is solid but Amgen dropped AMG 513, a pipeline write-off that tempers enthusiasm; the +3.3% is proportionate; at $357 analyst target, limited near-term upside suggests hold, no new position.

DIS (Walt Disney) — EPS: $6.38 | Stock: +2.4% | Reported: Recent The reaction was understated — beating Q3 estimates on strong experiences demand while exiting the A+E Media stake is strategically clean; Disney’s streaming-to-parks pivot is working and the muted +2.4% reaction looks like an underappreciated setup for patient longs.

VRTX (Vertex Pharmaceuticals) — EPS: $17.14 | Stock: +2.7% | Reported: Recent The reaction was fair to slightly undercooked — revenue beat with raised 2026 guidance but EPS slightly lagged; the core CF franchise remains dominant and pain pipeline is intact; hold at current levels with the $558 analyst target implying meaningful upside over time.

MAR (Marriott International) — EPS: $9.49 | Stock: +2.4% | Reported: Recent The